Filter Results:
(5,040)
Show Results For
- All HBS Web
(5,040)
- People (18)
- News (1,728)
- Research (2,519)
- Events (8)
- Multimedia (63)
- Faculty Publications (1,180)
Show Results For
- All HBS Web
(5,040)
- People (18)
- News (1,728)
- Research (2,519)
- Events (8)
- Multimedia (63)
- Faculty Publications (1,180)
- May 2008 (Revised December 2010)
- Case
Chi Mei Optoelectronics
By: Willy C. Shih, Chintay Shih, Jyun-Cheng Wang and Ho Howard Yu
Chi Mei is a Taiwanese industrial group that makes a major diversification into the technology intensive TFT-LCD flat panel display industry. Because the diversification is far away from its core competence in petrochemicals, it is an opportunity to examine how the... View Details
Keywords: Globalized Firms and Management; Supply Chain; Corporate Strategy; Diversification; Information Technology; Electronics Industry; Manufacturing Industry; China; South Korea; Taiwan
Shih, Willy C., Chintay Shih, Jyun-Cheng Wang, and Ho Howard Yu. "Chi Mei Optoelectronics." Harvard Business School Case 608-123, May 2008. (Revised December 2010.)
- Web
Overview - Doctoral
Overview New Ideas for a Changing World PhD Programs Accounting & Management Business Economics (Includes Finance) Health Policy (Management) Marketing Organizational Behavior Strategy Technology &... View Details
- 26 Nov 2013
- First Look
First Look: November 26
http://www.ajmc.com/publications/issue/2013/2013-1-vol19-n9/Testimonials-Do-Not-Convert-Patients-From-Brand-to-Generic-Medication August 2013 Health Affairs Lessons from England's Health Care Workforce... View Details
Keywords: Sean Silverthorne
- 12 Jan 2017
- News
What Cancer Researchers Can Learn from Direct-to-Consumer Companies
- June 2010 (Revised December 2010)
- Case
Hôpital de Pontoise
By: Richard M.J. Bohmer, Daniela Beyersdorfer and Simon Harrow
In 2010, Andre Razafindranaly, managing director of a large French public hospital, considers which organizational structure will help them adjust to the changing health sector environment. The move from global budget to activity-based funding has led his and many... View Details
Keywords: Activity Based Costing and Management; Governance Controls; Governing Rules, Regulations, and Reforms; Health Care and Treatment; Leading Change; Service Delivery; Organizational Change and Adaptation; Organizational Structure; Health Industry; France
Bohmer, Richard M.J., Daniela Beyersdorfer, and Simon Harrow. "Hôpital de Pontoise." Harvard Business School Case 610-100, June 2010. (Revised December 2010.)
- Program
Leading and Building a Culture of Innovation
Summary Today's leaders are evolving their approaches to leadership and innovation in response to quantum shifts in how we work and live. In the midst of economic, societal, and technological disruptions, leaders must build and lead agile View Details
- January 2001 (Revised May 2003)
- Case
Novartis Pharma: The Business Unit Model
By: Srikant M. Datar, Carin-Isabel Knoop and Cate Reavis
In June 2000, Novartis reorganized its pharmaceutical business to form global business units in oncology, transplantation, ophthalmology, and mature products. The remaining primary care products continued to be managed within global functions (e.g., R&D and marketing).... View Details
Keywords: Restructuring; Recruitment; Product Marketing; Organizational Structure; Problems and Challenges; Health Industry; Health Industry
Datar, Srikant M., Carin-Isabel Knoop, and Cate Reavis. "Novartis Pharma: The Business Unit Model." Harvard Business School Case 101-030, January 2001. (Revised May 2003.)
- January 2011 (Revised January 2012)
- Case
The Case of the Unidentified Healthcare Companies2010
By: Richard Bohmer, Ethan Bernstein, Margarita Krivitski and Srinidhi Reddy
This case presents financial statements and selected ratios for 14 unidentified healthcare organizations and asks that each set of financial information be matched with one of the following healthcare companies: a biotechnology firm, a community nursing company, a... View Details
Bohmer, Richard, Ethan Bernstein, Margarita Krivitski, and Srinidhi Reddy. "The Case of the Unidentified Healthcare Companies2010." Harvard Business School Case 611-043, January 2011. (Revised January 2012.)
- Program
Launching New Ventures
innovation in established firms Complementary Program Advance your learning through Foundations of Private Equity and Venture Capital, offered the week following Launching New Ventures, which delves into entrepreneurial finance and offers advice for navigating the... View Details
- 17 Dec 2012
- Research & Ideas
Teaming in the Twenty-First Century
collaboration are essential, but they happen in fluid arrangements, rather than in static teams. Read the Book Excerpt In her new book, Teaming: How Organizations Learn, Innovate, and Compete in the Knowledge Economy, Edmondson says that... View Details
Keywords: by Maggie Starvish
- August 2023 (Revised August 2023)
- Case
Sky Therapeutics: Innovating in Digital Therapeutics
By: Satish Tadikonda, Olivia Reszczynski and William Marks
Shad Faraz and Alex Youssef were intrigued by the opportunities in the relatively new area of Digital Therapeutics. Despite initial successes, early entrants had struggled with reimbursement and revenue-predictability challenges. However, venture investors still... View Details
Keywords: Business Startups; Entrepreneurship; Mission and Purpose; Health Industry; Health Industry
Tadikonda, Satish, Olivia Reszczynski, and William Marks. "Sky Therapeutics: Innovating in Digital Therapeutics." Harvard Business School Case 824-023, August 2023. (Revised August 2023.)
- 10 Jan 2013
- Working Paper Summaries
The Novelty Paradox & Bias for Normal Science: Evidence from Randomized Medical Grant Proposal Evaluations
- 11 Dec 2008
- Working Paper Summaries
Quality Management and Job Quality: How the ISO 9001 Standard for Quality Management Systems Affects Employees and Employers
Keywords: by David I. Levine & Michael W. Toffel
- April 2018 (Revised September 2018)
- Case
Impact Investing for Cancer
By: Richard G. Hamermesh and Matthew G. Preble
It is early 2018, and Emily Park, managing director of impact for the Abreu Family Office, is meeting the next day with Tomás and Maria Abreu to discuss the various ways in which the Abreus can allocate a planned $100 million to make a meaningful difference in cancer... View Details
Keywords: Impact Investing; Investment; Health Disorders; Philanthropy and Charitable Giving; Decision Choices and Conditions
Hamermesh, Richard G., and Matthew G. Preble. "Impact Investing for Cancer." Harvard Business School Case 818-068, April 2018. (Revised September 2018.)
- July 2013 (Revised March 2015)
- Case
Carl Zeiss and Free-Form Production: Can We See Clearly Yet?
By: Willy Shih
The prescription eyeglass lens industry was complicated and highly fragmented, and even though many of the tools and techniques employed have been relatively unchanged over the last century, there was still a surprising pace of innovation. An aging population around... View Details
Keywords: History; Demand and Consumers; Disruptive Innovation; Vertical Integration; Theory; Technology Adoption; Health Industry
Shih, Willy. "Carl Zeiss and Free-Form Production: Can We See Clearly Yet?" Harvard Business School Case 614-007, July 2013. (Revised March 2015.)
- March 2010 (Revised June 2010)
- Case
Whose Money Is It Anyway? (A)
By: V.G. Narayanan, Richard G. Hamermesh and Rachel Gordon
The Brigham and Women's Physician's Organization (BWPO) and its corporate parent disagree over who has jurisdiction over significant legacy funds. Are they controlled by the BWPO or do they belong to BWPO's corporate parent? The BWPO and its corporate parent must... View Details
Keywords: Accounting; Investment Funds; Governance Controls; Agreements and Arrangements; Boundaries; Health Industry
Narayanan, V.G., Richard G. Hamermesh, and Rachel Gordon. "Whose Money Is It Anyway? (A)." Harvard Business School Case 810-008, March 2010. (Revised June 2010.)
- 11 Mar 2020
- News
Zooming into Remote Work: A Virtual Conversation
- Program
Aligning Strategy and Sales
Summary A company's sales organization is a core vehicle for implementing business strategy—yet there's often a big gap between the company's strategic objectives and the way its sales organization actually... View Details
- Article
Unhealthy Consumerism: The Challenge of Trading Off Price and Quality in Healthcare
By: Kate Barasz and Peter A. Ubel
Over the last decade, healthcare in many parts of the world has shifted toward a more patient-centric, consumeristic model, marked by an emphasis on choice and a proliferation of typical consumer-facing information (e.g., price and quality data). However, while the... View Details
Keywords: Medical Decision-making; Choice; Health Care and Treatment; Quality; Price; Consumer Behavior; Decision Making
Barasz, Kate, and Peter A. Ubel. "Unhealthy Consumerism: The Challenge of Trading Off Price and Quality in Healthcare." Behavioural Public Policy 2, no. 1 (May 2018): 41–55.
- 31 Jan 2011
- Research & Ideas
Taking the Fear out of Diversity Policies
on the benefits of a diverse organization will lead to workplace policies that embrace diversity, instead of grudgingly accepting it or pussyfooting around it. "A lot of policies in the workplace about diversity are based on research... View Details
Keywords: by Carmen Nobel